Chemplast Sanmar Ltd (CHEMPLASTS)
๐ฏ Key Takeaways
- Chemplast Sanmar Ltd is navigating a challenging phase marked by persistent losses, declining margins, and operational volatility in its core commodity chemicals segment, despite stable promoter holding and shareholder confidence. The company has seen a deterioration in ROE and ROCE, with negative profitability across recent quarters, suggesting structural headwinds rather than temporary setbacks.
- Revenue declined 10.4% QoQ to โน1,125 in Q1FY27.
- โ ๏ธ Structural margin compression in the commodity chemicals segment, exacerbated by the fire incident at Karaikal and lack of recovery strategy.
- Market Cap
- โน3,097
- P/B Ratio
- 1.77
- ROE
- -22.3%
- ROCE
- -7.6%
- Debt/Equity
- 1.11
- Promoter
- 55.0%
๐ The Story
Chemplast Sanmar Ltd is navigating a challenging phase marked by persistent losses, declining margins, and operational volatility in its core commodity chemicals segment, despite stable promoter holding and shareholder confidence. The company has seen a deterioration in ROE and ROCE, with negative profitability across recent quarters, suggesting structural headwinds rather than temporary setbacks.
๐ฐ What's Happening
Management has maintained leadership continuity with the reappointment of MD S Ganeshkumar for three years, approved by the Central Government in August 2026, reinforcing governance stability. The company denied rumors of acquiring Symed Labs to preempt market speculation, reflecting caution around M&A activity. Shareholders endorsed all AGM resolutions, including cost audit ratification and independent director remuneration, indicating confidence in current governance. Most recently, the board approved Q1 FY27 results showing revenue growth to โน1,124.66 crores but also highlighted a fire incident at the Karaikal plant and an impairment provision tied to subsidiary CCVL, underscoring operational fragility.
Source: Stock Announcements
๐ Quarterly Results (โน Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 1,033 | 835 | 1,256 | 1,125 |
| Operating Profit | -9 | -110 | 140 | -176 |
| OPM % | -0.9% | -13.2% | 11.1% | -15.6% |
| Net Profit | -51 | -119 | -45 | -176 |
| EPS | โน-3.21 | โน-7.45 | โน-2.87 | โน-11.10 |
Revenue has fluctuated over the past four quarters, peaking at โน1,256 crores in Q4 FY26 before declining to โน1,125 crores in Q1 FY27, despite no major new product launches or capacity expansions disclosed. Operating profitability has deteriorated sharply, with standalone OPM turning negative at -15.6% in Q1 FY27 from 11.1% in the prior quarter, driven by margin compression in the commodity chemicals segment. Net losses widened to โน-176 crores in Q1 FY27 from โน-45 crores in Q4 FY26, reflecting both operational underperformance and non-recurring charges, including an impairment provision and fire-related disruptions, which management has not yet linked to a recovery plan.
๐ฎ Management Outlook & What's Next
No forward guidance was provided in the latest financial results filing or accompanying investor materials, leaving the trajectory of the commodity chemicals segment and recovery from the Karaikal plant incident unclear. Management has not articulated a detailed strategy to address margin pressures or reinvest in higher-margin segments, despite repeated references to ongoing operational challenges in the commodity space.
Extracted from official company announcements. Not StockFin.ai's opinion.
๐ฆ Balance Sheet (โน Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 79 | 79 | 79 | 79 |
| Reserves | 1,989 | 1,660 | 1,676 | 1,874 |
| Borrowings | 1,842 | 1,525 | 1,952 | 1,889 |
| Total Liabilities | 6,503 | 6,088 | 6,315 | 6,473 |
| Fixed Assets | 4,493 | 3,918 | 4,386 | 4,440 |
| Investments | 0 | 0 | 8 | 8 |
| Total Assets | 6,503 | 6,088 | 6,315 | 6,473 |
The balance sheet shows stable equity at โน79 crores over the past two fiscal years, with reserves declining slightly from โน1,989 to โน1,874 crores, indicating limited internal capital generation. Borrowings remain elevated at โน1,952 crores as of March 2026, up from โน1,842 crores a year ago, suggesting reliance on debt to fund operations or investments without a corresponding improvement in profitability. Total assets have plateaued near โน6,300-6,500 crores, showing no aggressive expansion, while the debt-to-equity ratio of 1.11 signals moderate leverage but limited financial flexibility given the earnings volatility.
๐ฐ Cash Flow Statement (โน Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +294 |
| Investing | -232 |
| Financing | -187 |
| Net Cash Flow | -124 |
๐ฅ Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 55.0% | 55.0% | 55.0% | 55.0% |
| FII | 13.2% | 13.2% | 12.5% | 12.0% |
| DII | 25.6% | 25.5% | 25.6% | 23.7% |
| Public | 4.7% | 4.9% | 5.2% | 6.8% |
| # Shareholders | 64,908 | 64,051 | 62,594 | 64,604 |
Promoter holding remains stable at 54.99%, indicating no dilution or stake sale. However, institutional interest is eroding, with FII ownership declining from 13.16% in Q3 FY26 to 12.02% in Q1 FY27, and DII from 25.52% to 23.71% over the same period, suggesting foreign and domestic investors are reducing exposure amid persistent losses and sectoral headwinds. The growing number of public shareholders (64,604 in Q1 FY27) reflects retail interest but also potential fragmentation, with no clear catalyst for renewed institutional confidence.
โ๏ธ Peer Comparison โ Chemicals
| Company | MCap (โน Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.53 L Cr | 57.6 | 33.4% | โ | 0.01 |
| SRF | 73,810 | 34.1 | 15.6% | โ | 0.36 |
| LINDEINDIA | 52,814 | 96.7 | 17.5% | โ | 0.00 |
| FLUOROCHEM | 48,774 | 79.7 | 9.6% | โ | 0.34 |
| NAVINFLUOR | 43,256 | 54.7 | 22.2% | โ | 0.31 |
| GODREJIND | 36,153 | 30.8 | 9.2% | โ | 4.57 |
| HSCL | 33,807 | 42.0 | 20.7% | โ | 0.16 |
| AETHER | 23,029 | 97.7 | 13.8% | โ | 0.08 |
| DEEPAKNTR | 21,155 | 27.0 | 15.3% | โ | 0.26 |
| CASTROLIND | 19,891 | 18.7 | 76.2% | โ | 0.00 |
๐ Peer Stock Analyses
โ ๏ธ Risk Factors
1. Structural margin compression in the commodity chemicals segment, exacerbated by the fire incident at Karaikal and lack of recovery strategy. 2. Persistent net losses and negative ROE/ROCE with no clear path to profitability despite revenue stability. 3. Rising impairment charges, including a recent provision for subsidiary CCVL, signaling potential overvaluation or underperformance of investments. 4. Declining FII and DII holdings amid stagnant share price performance and sectoral underperformance, which could amplify volatility if selling pressure continues.
๐ Recent Filings
- Announcement2026-09-28Chemplast Sanmar Ltd announced that its trading window will close on 1 October 2026 for designated persons and their relatives until two trading days โฆ
- Announcement2026-09-26Chemplast Sanmar announced the provisional revocation of a prohibition order on its Karaikal EDC plant in Puducherry, allowing operations to restart aโฆ
- ๐ก Board Meeting2026-09-16Chemplast Sanmar announced the resignation of Non-Executive Director V S Radhakrishnan effective September 15, 2026, as per SEBI Regulation 30 disclosโฆ
- ๐ก Board Meeting2026-08-27Chemplast Sanmar announced Central Government approval for Mr. Ganeshkumar Subramanian's appointment as Managing Director for three years effective Apโฆ
- ๐ด Announcement2026-08-24Chemplast Sanmar Limited denied rumors of acquiring Symed Labs Limited in an August 24, 2026 regulatory filing with BSE and NSE. The company clarifiedโฆ
- ๐ก Board Meeting2026-08-10Chemplast Sanmar Limited announced voting results from its 42nd Annual General Meeting held on 7 August 2026, where shareholders approved all five ordโฆ
- ๐ก Board Meeting2026-08-06Chemplast Sanmar Limited approved its unaudited standalone and consolidated financial results for the quarter ended 30 June 2026 during a board meetinโฆ
- ๐ด Financial Results2026-08-04Chemplast Sanmar Limited announced an earnings conference call scheduled for August 7, 2026 at 11:00 AM IST to discuss Q1 FY27 operational and financiโฆ
- Announcement2026-07-23Chemplast Sanmar announced that the Puducherry Pollution Control Committee ordered the immediate closure of its EDC plant in Karaikal following a fireโฆ
- Announcement2026-07-20Chemplast Sanmar Limited disclosed a regulatory prohibition order issued by Puducherry's Chief Inspector of Factories on July 19, 2026, halting operatโฆ
๐ง Analyst's Read
Chemplast Sanmar remains in a fragile operational and financial position, with management acknowledging commodity segment challenges but offering no concrete turnaround roadmap. Investors should monitor the next earnings call for updates on plant recovery, margin improvement initiatives, or any shift in capital allocation strategy, as current trends suggest limited near-term upside without operational stabilization.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights โ sign up free to unlock.
Sign Up Free โ Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only โ not investment advice. Updated 2026-09-29.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when CHEMPLASTS files new disclosures
Track CHEMPLASTS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CHEMPLASTS โ FreeFree account ยท 2 AI queries/day